WuXi AppTec appeared to be the Corporate Investor, which was created in 2000. The main department of described Corporate Investor is located in the Shanghai. The venture was found in Asia in China.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Hua Medicine, DNAnexus, Schrodinger. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most successful fund investment fields, there are Health Care, Real Time.
The fund was created by Ge Li, John J. Baldwin, Zhaohui Zhang. The overall number of key employees were 2.
Opposing the other organizations, this WuXi AppTec works on 20 percentage points less the average amount of lead investments. The increased amount of exits for fund were in 2018. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. Considering the real fund results, this Corporate Investor is 2 percentage points less often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 6-7 partakers. Despite the WuXi AppTec, startups are often financed by Venrock, WuXi Healthcare Ventures, First Round Capital. The meaningful sponsors for the fund in investment in the same round are ARCH Venture Partners, Sequoia Capital China, Watson Fund. In the next rounds fund is usually obtained by Invus, WuXi NextCODE, WuXi Healthcare Ventures.
Related Funds
| Fund Name | Location |
| AlphaCoin Fund | Boston, Massachusetts, United States |
| Asahi Medialab Ventures | Chiyoda, Japan |
| Bet Haemek | - |
| CDC IXIS Innovation | France, Ile-de-France, Paris |
| Enza Capital | Kenya, Nairobi, Nairobi Area |
| Goff Capital | Fort Worth, Texas, United States |
| Hotbit | China, Shanghai |
| Huigu Chuang Tou | Changning, China, Shanghai |
| Innogenetics | Belgium, Gent, Oost-Vlaanderen |
| Kodak | New York, Rochester, United States |
| Natco Pharma | Andhra Pradesh, Hyderabad, India |
| Red Hat | North Carolina, Raleigh, United States |
| Sesame Street | Alabama, America, United States |
| Shigin Economic Research Institute | - |
| Software Holding & Finance | Belgium, Flemish Brabant, Vlaams-Brabant |
| Starstrike Ventures | Berlin, Berlin, Germany |
| Telegraph Hill Capital | California, San Francisco, United States |
| Treasury | New York, New York, United States |
| Upfront Ventures Community Fund | California, Los Angeles, United States |
| Yidou Investment | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
D3 Bio | $62M | 08 Apr 2024 | Shanghai, China | ||
Bioyond Tech | $30M | 03 Apr 2023 | Pudong, Shandong, China | ||
ShouTi | $100M | 20 Oct 2021 | Shanghai, China | ||
Stemirna | $185M | 03 Jun 2021 | Dongcheng District, Beijing, China | ||
Engine Biosciences | $43M | 26 May 2021 | San Francisco, California, United States | ||
OakMega | 10 May 2021 | New Taipei, Taiwan | |||
AnchorDx | $40M | 22 Feb 2021 | Guangdong Province | ||
| $56M | 09 Feb 2021 | Shanghai, China | |||
| $200M | 17 Nov 2020 | Shanghai, China |
– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.
– Engine Biosciences announced the successful completion of an oversubscribed $43m Series A funding round.
– Engine identifies errors in the complex genetic codes of diseases, fixing them with precise therapeutic solutions.
– This round was led by Polaris Partners and also included new investors Invus and one of the world’s premier institutional investors, based in Singapore.
– Existing investors also participated in the Series A, which included 6 Dimensions Capital, WuXi AppTec, DHVC, EDBI, Baidu Ventures, Vectr Ventures, Goodman Capital, WI Harper, and Nest.Bio.
– Amy Schulman, Managing Partner at Polaris Partners, has joined the Engine Biosciences Board of Directors.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
D3 Bio | $62M | 08 Apr 2024 | Shanghai, China | ||
Bioyond Tech | $30M | 03 Apr 2023 | Pudong, Shandong, China | ||
ShouTi | $100M | 20 Oct 2021 | Shanghai, China | ||
Stemirna | $185M | 03 Jun 2021 | Dongcheng District, Beijing, China | ||
Engine Biosciences | $43M | 26 May 2021 | San Francisco, California, United States | ||
OakMega | 10 May 2021 | New Taipei, Taiwan | |||
AnchorDx | $40M | 22 Feb 2021 | Guangdong Province | ||
| $56M | 09 Feb 2021 | Shanghai, China | |||
| $200M | 17 Nov 2020 | Shanghai, China |
